A · Multisensory wearable
Browser vision/audio now; external tracking and approved wearable adapters later. No thermal, scent or taste actuation is implemented.
Phase 5 software → Phase 8 hardware
B · Immersion pod
Begin with comfortable seated access and software interfaces. Mechanical motion, force and climate require separately verified hardware safeguards.
Incremental partner prototype
C · EEG / EMG / eye / body input
Normalized intent envelopes and mock replay can be prepared. Real acquisition, calibration and intent models require a verified SDK and consent review.
Research adapter track
D · Peripheral nerve interface
No nerve stimulation, targeting or procedures in the software release.
Later clinical partnership
E · Non-invasive neuromodulation
TMS, tES and focused ultrasound are not software output adapters. No operational parameters or controls are exposed.
Later supervised investigation
F · Endovascular BCI
Read/control possibilities are not equivalent to immersive sensory write-in. No clinical integration is connected.
Clinical investigation
G · Cortical surface interface
Professional research partnership only; not a Phase 5 consumer feature.
Clinical research
H · Intracortical BCI
No invasive implementation, neural write-in or full-sensory claims.
Advanced clinical research
I · Injectable / flexible electronics
No injectable device, material deployment or manufacturing procedure is provided.
Long-horizon investigation
J · Distributed nanoparticles
Concept research only. No pill, field generator or distributed neural-interface product exists in this release.
Speculative horizon
K · DreamBridge
No sleep-state acquisition, dream director or deterministic dream control is implemented.
Sleep research horizon
L · Hybrid stack
Build conventional presence first, then add independently verified adapters. Never make WorldCore depend on a single future neural breakthrough.
Recommended modular architecture
Evidence before promotion.
Verified provider contract, compatibility and licensing, appropriate ethics and local regulatory review, participant consent and data minimization, measured latency and failure behaviour, emergency stop and independent safety testing.
The FDA link is a US research reference, not approval in your jurisdiction. Future clinical studies require independent local professional and ethics oversight.